Picture of Phaxiam Therapeutics SA logo

PHXM — Phaxiam Therapeutics SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapValue Trap

Brief: Erytech Announces Approval To Transfer Its Listing To The Nasdaq Capital Market

April 17 (Reuters) - Erytech Pharma SA  ERYP.PA :
    * ERYTECH ANNOUNCES APPROVAL TO TRANSFER ITS LISTING TO THE
NASDAQ
CAPITAL MARKET

Source text for Eikon:  ID:nGNXb0nmgb 
Further company coverage:  ERYP.PA 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Phaxiam Therapeutics SA

See all news